Epizyme: Q2 Earnings Snapshot
CAMBRIDGE, Mass. (AP) _ Epizyme Inc. (EPZM) on Tuesday reported a loss of $35.7 million in its second quarter.
The Cambridge, Massachusetts-based company said it had a loss of 21 cents per share.
The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 36 cents per share.
The biopharmaceutical company posted revenue of $27.5 million in the period, also beating Street forecasts. Three analysts surveyed by Zacks expected $10.1 million.